Decibel Therapeutics Inc

DBTX
4,91
0,00 (0,00%)
Ultimo aggiornamento: 02:00:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
10/10/202322:56EDGAR2Form 15-12G - Securities registration termination [Section..
25/9/202322:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/9/202322:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/9/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/9/202322:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/9/202322:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/9/202315:09EDGAR2Form S-8 POS - Securities to be offered to employees in..
25/9/202315:00EDGAR2Form POS AM - Post-Effective amendments for registration..
25/9/202314:56EDGAR2Form 8-K - Current report
25/9/202314:53EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
12/9/202322:12EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
08/9/202322:23EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
25/8/202315:17EDGAR2Form SC 14D9 - Solicitation, recommendation statements
25/8/202313:04EDGAR2Form 8-K - Current report
11/8/202313:45GLOBEDecibel Therapeutics Reports Second Quarter 2023 Financial..
11/8/202313:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202322:55EDGAR2Form SC14D9C - Written communication relating to third party..
09/8/202315:34DJNDecibel Therapeutics Shares Surge on Regeneron Acquisition
09/8/202314:14DJNRegeneron To Acquire Decibel Therapeutics
09/8/202314:02EDGAR2Form 8-K - Current report
09/8/202313:30GLOBERegeneron to Acquire Decibel Therapeutics, Strengthening..
02/6/202313:00GLOBEDecibel Therapeutics to Participate in the Upcoming..
01/6/202322:30GLOBEDecibel Therapeutics to Present DB-020 Phase 1b Clinical..
17/5/202322:30GLOBEDecibel Therapeutics to Participate in the Upcoming Barclays..
15/5/202313:45GLOBEDecibel Therapeutics Reports First Quarter 2023 Financial..
12/5/202313:00GLOBEDecibel Therapeutics Announces Approval of Clinical Trial..
10/5/202322:30GLOBEDecibel Therapeutics to Present at the American Society of..
Apertura: Min: Max:
Chiusura: 4,91

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network